retinoic acid related orphan receptor antagonists (Visionary Pharmaceuticals)

N/A

Report date: 2025/06/11 11:08:24
NME

Base Information

Drug Nameretinoic acid related orphan receptor antagonists (Visionary Pharmaceuticals)
Drug Alias NameVPR-254VPR-66VPR-7
ClassificationSmall molecules
Mechanisms of ActionRetinoic acid receptor gamma inhibitorsImmunomodulators
TargetsRetinoic acid receptor gamma
Therapy Area/IndicationsInflammationAutoimmune DiseasesMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVisionary Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesVisionary Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsInflammationAutoimmune DiseasesMetabolic Dysfunction-Associated Steatotic Liver Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A